Recruiting OBSERVATIONAL NCT02883335

Lorraine Registry of Multiple Sclerosis (RelSEP)

Sponsor: Central Hospital, Nancy, France

Updated 8 times since 2017 Last updated: Feb 6, 2023 Started: May 31, 2003 Primary completion: Jan 31, 2030 Completion: Jan 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02883335, this observational or N/A phase trial focuses on Multiple Sclerosis and remains actively recruiting participants. Sponsored by Central Hospital, Nancy, France, it has been updated 8 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2023 — Jul 2024 [monthly]

Recruiting
Jan 2021 — Mar 2023 [monthly]

Recruiting
Sep 2018 — Jan 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Jun 2018 — Sep 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

May 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France
University of Lorraine

Data source: Central Hospital, Nancy, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nancy, France